Biotech
> Advaxis ($ADXS) appointed former Secretary of Homeland Security and former Pennsylvania Gov. Tom Ridge to its board of directors. Release
> HemisphereX ($HEB) Biopharma named Thomas Equels as president. Release
> Rich Fante joined Innocoll ($INNL) as chief commercial officer and head of business development. Release
> Cantex Pharma appointed Juan Rodriguez as chief financial officer and Karen Ivester as vice president of clinical operations. Release
> Pamlico Biopharma elected Dr. Mark Corrigan to its board of directors. Release
> Ischemix added Dr. Peter Milner to its board of directors. Release
> CRISPR Therapeutics added Samarth Kulkarni as its chief business officer and Michael Bruce as a senior vice president. Release
> Marathon Pharma appointed Babar Ghias as chief financial officer. Release
> Greg Kitchener joined BioPharmX as chief financial officer. Release
> BioDelivery Sciences ($BDSI) appointed Scott Plesha as senior vice president of sales. Release
> Dimension Therapeutics added Georges Gemayel and Arlene Morris to its board of directors. Release
> Celmatix appointed Daniel Farkas as chief clinical laboratory officer. Release
> Cellular Biomedicine Group ($CBMG) named Yihong Yao, formerly of AstraZeneca's ($AZN) MedImmune, as chief scientific officer. Release
> Rich Pharmaceuticals appointed Richard Salvador to its board of directors. Release
> Horizon Pharma ($HZNP) named George Hampton as executive vice president, global orphan business unit and international operations. Release
> Transgenomic ($TBIO) appointed Scott Patterson, Dr. Bruce Johnson and Dr. Paul Waring to its new clinical-commercial advisory board. Release
> Chad Cohen joins Adaptive Biotech as chief financial officer. Release
> MannKind ($MNKD) named Dr. Raymond Urbanski as chief medical officer. Release
> Chiasma appointed Anand Varadan as chief commercial officer. Release
Med Tech
> Monteris Medical appointed James Reinstein to its board of directors. Release
> BrainScope appointed Dr. Leslie Prichep as chief scientific officer, Kerstin Schultz as president and chief operating officer, Laurie Silver as chief financial officer and Angad Singh as chief technology officer. Release
> Invuity ($IVTY) named James Mackaness as chief financial officer. Release
Diagnostics
> Check-Cap appointed William Densel as CEO and director. Release
> Roka Bioscience ($ROKA) added Nicholas Valeriani to its board of directors. Release
> BioMark Diagnostics named Thomas Malcolm as chief scientific officer and head of U.S. operations. Release
Animal Health
> Parnell Pharma added Peter Croden to its board of directors. Release
Vaccines
> The International AIDS Vaccine Initiative tapped Dr. Mark Feinberg as president and CEO. Release
|